Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease
about
Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe.Tissue factor-dependent coagulation activation by heme: A thromboelastometry study.Vasculopathy and pulmonary hypertension in sickle cell disease.Excess of heme induces tissue factor-dependent activation of coagulation in mice.Toll-like receptor 9 signaling regulates tissue factor and tissue factor pathway inhibitor expression in human endothelial cells and coagulation in mice.Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease miceNeutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease miceDifferential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.Interplay between coagulation and vascular inflammation in sickle cell disease.The trials and hopes for drug development in sickle cell disease.Prothrombotic aspects of sickle cell disease.Helicobacter Infection Significantly Alters Pregnancy Success in Laboratory Mice.Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease.Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function.Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.Developing new pharmacotherapeutic approaches to treating sickle-cell disease.Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia.
P2860
Q33574142-31210A63-741D-459D-B4D0-5077017EACE5Q33596569-3FB4DEFB-BCAB-4076-9B82-766D0AD06983Q35086394-EAFB77F7-BF37-46EA-9DB0-AB640227134BQ35146268-2825662B-E5FF-4341-A300-5C371DA65315Q35606414-EBB1B23C-4B22-44D0-BE84-73BF99CA710CQ36143261-BE1413E3-ED61-4A0E-9159-1823DA9245E1Q36596850-035ED1A6-D726-4FCC-A68E-845900A86987Q37033939-E85B38FD-9043-4507-89E7-C77ACEE0ACEFQ37222670-627D3AF6-E7C6-47CB-88A2-07D883036966Q37636986-A89072D0-4314-4DC7-B65C-07DD4A8BFE50Q38099667-55F67045-AB4B-4873-A806-C1BFBC0A6F19Q38540335-6EF4E0B0-5C48-4F16-83C2-D72CBA35B099Q38696998-E150EA50-B91E-416E-B3E3-FBD589BE536AQ38768538-7DD5CF71-5A6A-4B45-98BC-F4EB7F61E924Q39588275-F2C1F17C-CDD0-45C0-882D-09A8195F4663Q42687701-0D22C5A5-BF34-4526-AB5B-990C58A63CFCQ42760191-3F5DDABF-E3E9-4E42-8D9E-1BC009AE4956Q47189835-47B22326-11A9-4D13-B99C-FCF7A9A27DB2Q50207951-49969627-5BF3-4F54-BA44-62F4F5C23CA5Q54299957-413B9F1A-ABD5-4DF1-B373-803383CBD796
P2860
Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tissue factor promotes activat ...... e model of sickle cell disease
@ast
Tissue factor promotes activat ...... e model of sickle cell disease
@en
type
label
Tissue factor promotes activat ...... e model of sickle cell disease
@ast
Tissue factor promotes activat ...... e model of sickle cell disease
@en
prefLabel
Tissue factor promotes activat ...... e model of sickle cell disease
@ast
Tissue factor promotes activat ...... e model of sickle cell disease
@en
P2093
P2860
P1433
P1476
Tissue factor promotes activat ...... e model of sickle cell disease
@en
P2093
Daniel Kirchhofer
Erica Sparkenbaugh
Jian-Guo Wang
Leslie V Parise
Nigel S Key
Pichika Chantrathammachart
Rafal Pawlinski
P2860
P304
P356
10.1182/BLOOD-2012-04-424143
P407
P577
2012-06-01T00:00:00Z